학술논문
Change in Bacterial Causes of Community-Acquired Parapneumonic Effusion and Pleural Empyema in Children 6 Years After 13-Valent Pneumococcal Conjugate Vaccine Implementation.
Document Type
Article
Author
Source
Subject
*EMPYEMA
*IMMUNIZATION
*MEDICAL protocols
*PEDIATRICS
*PLEURAL effusions
*PNEUMOCOCCAL vaccines
*STREPTOCOCCAL diseases
*COMMUNITY-acquired pneumonia
*TREATMENT effectiveness
*HUMAN services programs
*EVALUATION of human services programs
*DISEASE complications
*CHILDREN
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
2048-7193
Abstract
We describe here changes in the bacterial causes of pleural empyema before and after implementation of the 13-valent pneumococcal conjugate vaccine (PCV13) program in France (2009–2017). For 220 (39.3%) of 560 children, a bacterial cause was found. The frequency of pneumococcal infection decreased during the study from 79.1% in 2009 to 36.4% in 2017 (P <.001). Group A streptococcus is now the leading cause of documented empyema (45.5%). [ABSTRACT FROM AUTHOR]